These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15572191)

  • 1. BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci.
    Domenico P; Gurzenda E; Giacometti A; Cirioni O; Ghiselli R; Orlando F; Korem M; Saba V; Scalise G; Balaban N
    Peptides; 2004 Dec; 25(12):2047-53. PubMed ID: 15572191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide.
    Dell'Acqua G; Giacometti A; Cirioni O; Ghiselli R; Saba V; Scalise G; Gov Y; Balaban N
    J Infect Dis; 2004 Jul; 190(2):318-20. PubMed ID: 15216467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides.
    Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Gov Y; Kamysz W; Lukasiak J; Mocchegiani F; Orlando F; D'Amato G; Balaban N; Saba V; Scalise G
    Circulation; 2003 Aug; 108(6):767-71. PubMed ID: 12885754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis.
    Balaban N; Giacometti A; Cirioni O; Gov Y; Ghiselli R; Mocchegiani F; Viticchi C; Del Prete MS; Saba V; Scalise G; Dell'Acqua G
    J Infect Dis; 2003 Feb; 187(4):625-30. PubMed ID: 12599079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis.
    Ghiselli R; Giacometti A; Cirioni O; Dell'Acqua G; Mocchegiani F; Orlando F; D'Amato G; Rocchi M; Scalise G; Saba V
    Eur J Vasc Endovasc Surg; 2004 Jun; 27(6):603-7. PubMed ID: 15121110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.
    Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Orlando F; Mocchegiani F; Silvestri C; Licci A; Saba V; Scalise G; Balaban N
    J Infect Dis; 2006 Jan; 193(2):180-6. PubMed ID: 16362881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP.
    Balaban N; Cirioni O; Giacometti A; Ghiselli R; Braunstein JB; Silvestri C; Mocchegiani F; Saba V; Scalise G
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2226-9. PubMed ID: 17371825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNAIII-inhibiting-peptide-loaded polymethylmethacrylate prevents in vivo Staphylococcus aureus biofilm formation.
    Anguita-Alonso P; Giacometti A; Cirioni O; Ghiselli R; Orlando F; Saba V; Scalise G; Sevo M; Tuzova M; Patel R; Balaban N
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2594-6. PubMed ID: 17116671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci.
    Balaban N; Gov Y; Giacometti A; Cirioni O; Ghiselli R; Mocchegiani F; Orlando F; D'Amato G; Saba V; Scalise G; Bernes S; Mor A
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2544-50. PubMed ID: 15215107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a quorum-sensing inhibitor of drug-resistant staphylococcal infections by structure-based virtual screening.
    Kiran MD; Adikesavan NV; Cirioni O; Giacometti A; Silvestri C; Scalise G; Ghiselli R; Saba V; Orlando F; Shoham M; Balaban N
    Mol Pharmacol; 2008 May; 73(5):1578-86. PubMed ID: 18314496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.
    Giacometti A; Cirioni O; Ghiselli R; Dell'Acqua G; Orlando F; D'Amato G; Mocchegiani F; Silvestri C; Del Prete MS; Rocchi M; Balaban N; Saba V; Scalise G
    Peptides; 2005 Feb; 26(2):169-75. PubMed ID: 15629527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus.
    Giacometti A; Cirioni O; Gov Y; Ghiselli R; Del Prete MS; Mocchegiani F; Saba V; Orlando F; Scalise G; Balaban N; Dell'Acqua G
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1979-83. PubMed ID: 12760879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection.
    Cirioni O; Giacometti A; Ghiselli R; Kamysz W; Silvestri C; Orlando F; Mocchegiani F; Vittoria AD; Kamysz E; Saba V; Scalise G
    Peptides; 2007 Jun; 28(6):1299-303. PubMed ID: 17537542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of staphylococcal biofilm-associated infections by the quorum sensing inhibitor RIP.
    Balaban N; Stoodley P; Fux CA; Wilson S; Costerton JW; Dell'Acqua G
    Clin Orthop Relat Res; 2005 Aug; (437):48-54. PubMed ID: 16056025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Sacar M; Sacar S; Kaleli I; Onem G; Turgut H; Goksin I; Ozcan V; Kaan Inan B; Duver H; Baltalarli A
    J Surg Res; 2007 May; 139(2):170-5. PubMed ID: 17292421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daptomycin and rifampin alone and in combination prevent vascular graft biofilm formation and emergence of antibiotic resistance in a subcutaneous rat pouch model of staphylococcal infection.
    Cirioni O; Mocchegiani F; Ghiselli R; Silvestri C; Gabrielli E; Marchionni E; Orlando F; Nicolini D; Risaliti A; Giacometti A
    Eur J Vasc Endovasc Surg; 2010 Dec; 40(6):817-22. PubMed ID: 20869272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci.
    Lee JY; Ko KS; Peck KR; Oh WS; Song JH
    J Antimicrob Chemother; 2006 Jun; 57(6):1110-5. PubMed ID: 16556639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-kill efficacy of antibiotics in combination with rifampin against Staphylococcus epidermidis biofilms.
    Gagnon RF; Richards GK; Kostiner GB
    Adv Perit Dial; 1994; 10():189-92. PubMed ID: 7999824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The differential activity of aminoglycoside antibiotics with rifampin explored in a kinetic in vitro model of implant-associated infection (Staphylococcus epidermidis).
    Richards GK; Morcos RJ; Gagnon RF
    Adv Perit Dial; 1994; 10():183-8. PubMed ID: 7999823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prophylactic efficacy of rifampicin-soaked graft in combination with systemic vancomycin in the prevention of prosthetic vascular graft infection: an experimental study.
    Sacar M; Goksin I; Baltalarli A; Turgut H; Sacar S; Onem G; Ozcan V; Adali F
    J Surg Res; 2005 Dec; 129(2):329-34. PubMed ID: 16360378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.